City of Hope National Medical Center
Locations
Transplant Summary
Overview
City of Hope is an NCI-designated Comprehensive Cancer Center. It has performed allogenic transplants since 1974 and has been an NMDP transplant center since 1989. Areas of research include DNA typing for donor selection, new agents for prevention and treatment of GVHD, use of peripheral stem cells, and reduced intensity or low-dose regimens for older patients or those with co-morbid medical conditions.This center has been performing allogeneic transplants since 1975 and has been an NMDP transplant center since September 1989.
Attending physicians
Adult - Viabhav Agrawal, Monzr Al Malki, Ibrahim Aldoss, Haris Ali, Joseph Alvarnas, Idoroenyi Amanam, Ahmed Aribi, Shukaib Arslan, Andrew Artz, John Baird, Pamela Becker, Amanda Blackmon, Azra Borogovac, Ball Brian, Lihua Elizabeth Budde, Ji-Lian M. Cai, Peter Curtin, Alexey Danilov, Len Farol, Stephen J Forman, James Godfrey, Scott Goldsmith, Alex Herrera, Myo Htut, Scott James, Murali Janakiram, Robert Jenq, Avyakta Kallam, Swetha Kambhampati, Niloufer Khan, Paul Koller, Amrita Krishnan, Larry Kwak, Sarah Lee, Alexandria Levine, Joshua Mansour, Guido Marcucci, Matthew Mei, Caligiuri Michael, Ryo Nakamura, Nitya Nathwani, Salman Otoukesh, Tycel Phillips, Hoda Pourhassan, Vinod Pullarkat, Steven Rosen, Michael Rosenzweig, Firoozeh Sahebi, Amandeep Salhotra, Karamjeet Sandhu, Geoffrey Shouse, Tanya Siddiqi, Eileen Smith, Ricardo Spielberger, Anthony Stein, Forrest Stewart, Jasmine Zain
Pediatric - Nicole Karras, Anna Pawlowska, Joseph RosenthalTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult and pediatricOther programs and services
City of Hope National Medical Center (Duarte) has resources for patients and their caregivers that provide an array of printed and electronic material, along with a selection of specialized classes. The center is equipped with employees to guide inquiries on treatment resources. Some resources include:
• Sheri & Les Biller Patient and Family Resource Center
• Notary
• HCT Discharge Class for Caregivers
• Caregivers Connect Group
• AYA Program – Adolescents and Young Adults Cancer Program
• On-Site HotelPatient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 1095 patients.The actual 1-year survival of these patients is 78%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 74.4% and 79.1%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
1593
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow10PBSC313Cord blood0Total323Unrelated donorMarrow14PBSC475Cord blood2Total491Total allogeneicMarrow24PBSC788Cord blood2Total814AutologousMarrowBoth marrow & PBSC 779PBSC—Cord blood—Total779Total combinedMarrowBoth marrow & PBSC 1591PBSC—Cord blood2Total1593Total pediatric transplants
50
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow18PBSC16Cord blood0Total34Unrelated donorMarrow9PBSC3Cord blood1Total13Total allogeneicMarrow27PBSC19Cord blood1Total47AutologousMarrowBoth marrow & PBSC 3PBSC—Cord blood—Total3Total combinedMarrowBoth marrow & PBSC 49PBSC—Cord blood1Total50All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-183619-4411245-6414765+62Total357Unrelated 0-181619-4410545-6416665+217Total504Autologous 0-18419-4413245-6437565+271Total782Total 0-185619-4434945-6468865+550Total1643Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
This center has separate survivorship programs for adult and pediatric patients.
Please select the program you are interested in.